Retatrutide Thailand

Typical overseas-import path

Intercontinental shipping risks

• ✕ 18–72h intercontinental flight · multiple hand-offs across airlines and customs hubs
• ✕ Customs delays — unpredictable holds, no temperature monitoring during inspection
• ✕ Multiple thermal-transition points — every transfer is a risk window above 8°C
• ✕ No real-time temperature log shared with patient
• ✕ Source pharmacy in a different jurisdiction — documentation gaps for the Thai patient

Our inside-Thailand workflow

Continuous 2–8°C, end to end

• Pharmacy-to-clinic same-day · no customs leg, no transcontinental flight
• Validated medical-thermal containers with TempTale temperature loggers reviewed at every handover
• HPLC + mass-spectrometry verified at point of dispense — every batch, before it ever leaves the pharmacy
• Certificate of Analysis traceable to production lot · available on request
• Dispensed under Thai pharmacy law · same regulatory framework as the patient receiving the medicine

Every batch verified before it leaves the pharmacy

HPLC (High-Performance Liquid Chromatography) and mass spectrometry confirm potency and authenticity of every release. A Certificate of Analysis traceable to its production lot is available on request — the same documentation pharmaceutical manufacturers issue to hospital purchasers.

What this means for you

Your Retatrutide arrives potent at the point of injection — and that is what matters for a temperature-sensitive peptide. Every vial is manufactured under the same international quality frameworks used in US and European pharmaceuticals (GMP · ISO 9001 · HACCP · Class 1000 cleanroom), verified by HPLC and mass spectrometry before dispense, and kept inside the 2–8°C window from the pharmacy in Bangkok to your address. A shorter cold-chain is a safer cold-chain — because the fewer transitions a peptide passes through, the more of its biological activity arrives intact. That is the medicine you are paying for, and that is what we engineer for.

GLP-1

Glucagon-Like Peptide-1

Slows gastric emptying, increases satiety, and reduces appetite. Same mechanism as Semaglutide (Wegovy and Ozempic).

GIP

Glucose-Dependent Insulinotropic Polypeptide

Enhances insulin sensitivity and reduces inflammation. The second mechanism in Tirzepatide (Mounjaro).

Glucagon

The Third Pathway

Increases energy expenditure and fat oxidation. Unique to Retatrutide — this third receptor is why it produces stronger results than dual-agonist medicines.

Phase 2 · Published 2023

The New England Journal of Medicine

The most-cited medical journal in the world · Jastreboff et al., 2023

338 adults with obesity, randomized to placebo or one of four Retatrutide doses (1, 4, 8, 12 mg weekly). At 48 weeks, the 12 mg group lost a mean of 24.2% of body weight versus 2.1% in the placebo group. Glycemic and lipid markers also improved. Most side effects were gastrointestinal and mild-to-moderate.

Phase 3 · TRIUMPH program (ongoing)

TRIUMPH-1, -2, -3, -4 · Eli Lilly

Multiple Phase 3 trials are enrolling tens of thousands of participants across obesity, type 2 diabetes, cardiovascular outcomes, and comparisons against current standards of care. Primary read-outs are expected over the coming years. Regulatory approval will depend on the totality of these data.

What is still being studied

Open scientific questions

Long-term safety beyond the trial duration, weight regain after discontinuation, comparative effectiveness against Tirzepatide head-to-head, and response variability across populations are all areas where evidence is still maturing. These are normal limitations of any pre-approval medicine and should be part of every individual decision.

Who tends to be considered a candidate

Phase 2 trial inclusion criteria focused on adults with a body mass index of 30 kg/m² or higher, or 27 kg/m² or higher with at least one weight-related comorbidity (such as hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease). Real-world consultations follow similar reasoning, with additional weight given to prior weight-loss attempts and overall health context.

When this medicine is generally not appropriate

Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2), history of pancreatitis, severe gastrointestinal disease, pregnancy or planned pregnancy, and certain psychiatric conditions are common reasons to choose a different approach. A full medical history should be reviewed before any decision.

Side-effect profile observed in research

Nausea, diarrhoea, constipation, and vomiting were the most frequently reported events in the Phase 2 trial, generally mild-to-moderate and most common during the dose-escalation phase. Slow titration is the standard mitigation. Less common but more serious considerations include pancreatitis, gallbladder events, and changes in heart rate — discussed individually before starting.

Regulatory and legal status

Retatrutide is not yet approved by the US FDA, EMA, or Thai FDA as a marketed medicine. It is currently accessed in Thailand under specialty peptide frameworks. Regulatory status varies by country — patients travelling internationally should clarify the rules in their home country before making any commitment.

Realistic expectations

Trial averages do not predict individual outcomes. Some participants in the 12 mg arm lost more than the mean; others lost less. Weight loss without parallel changes in nutrition, sleep, movement, and stress management tends to be less durable. The medicine is a tool, not a substitute for the underlying habits.

1 · Supply-chain transparency

Ask whether the clinic can name the upstream supplier and the compounding pharmacy. Many providers decline to disclose. A responsible clinic names the source, explains what documentation is and isn't available for specialty-peptide products, and is open about the limits — not just the strengths. (Our own supply chain is disclosed in the section directly below.)

2 · Cold-chain handling end-to-end

Peptides are temperature-sensitive. Ask how the product is stored at the clinic, how it is transported to you, and what the storage instructions are at home. Unbroken cold chain protects what you are paying for.

3 · Medical review before access

A short form is not a medical review. Expect — and request — a real discussion of your medical history, current medications, prior weight-loss attempts, and personal goals before any product changes hands.

4 · A documented titration and monitoring plan

There should be a clear, written plan for dose progression, what to do if side effects occur, and how progress will be reviewed. Ad-hoc "we'll see how it goes" is not adequate for a serious medicine.

5 · Honest framing of unknowns

A provider who only describes upside is not giving you the information you need to decide. Phase 3 read-outs are still pending. Long-term safety data is still maturing. A responsible consultation says so out loud.

6 · A clear path to discontinue or change course

You should know up front how to taper off the medicine, what to expect afterwards, and how to switch to an approved alternative such as Tirzepatide or Semaglutide if appropriate.

Direct sourcing — no overseas shipping risk

Our Asia-based pharmaceutical-grade supplier route stays within Thailand. Intercontinental shipping adds 18-72 hours of cold-chain transition points; our pharmacy-to-clinic workflow avoids them.

Licensed pharmacist-verified supply chain

Every batch is verified via HPLC and mass spectrometry to confirm potency and authenticity prior to dispense. Asia's leading licensed and accredited compounding pharmacy in Bangkok with 10+ years of hospital and clinic supply experience.

Medical-grade, certified manufacturing

Manufactured in a Class 1000 cleanroom-certified facility under CODEX GMP-certified standards, ISO 9001:2015 Quality Management System, and HACCP-certified safety controls throughout production. Every vial released carries a Certificate of Analysis traceable to its production lot.

Continuous cold-chain — inside Thailand

Continuous 2-8°C cold-chain logistics from pharmacy release to clinic to your address — no transcontinental shipping, no anonymous online seller in the chain. Dispensed under Thai pharmacy law.

What we do not claim — honest about the limits

Retatrutide is a compounded specialty peptide, not a finished pharmaceutical product. The full multi-page batch-release dossiers issued for FDA-approved medicines like Mounjaro or Wegovy are not standard documentation for compounded peptides anywhere on the market today. Any provider claiming to issue such dossiers for compounded Retatrutide is overpromising. We prefer to tell you what is actually available.

If approved alternatives are a better fit — we will say so

For patients who prefer the full pharmaceutical-grade documentation that comes with an FDA-approved product, Tirzepatide (Mounjaro) or Semaglutide (Wegovy) are usually the better choice. We will tell you that during the consultation if it applies to your situation.

Months 1–3

7,000 THB/mo

1 × 10 mg vial / mo · 2 mg/week

Initial response phase. Many patients reach their goal here.

Months 4–6

14,000 THB/mo

2 × 10 mg vials / mo · 4 mg/week

Optional step-up only if Months 1–3 plateau.

Months 7–9

21,000 THB/mo

3 × 10 mg vials / mo · 6 mg/week

Reserved for plateaus from Months 4–6.

Months 10–12

Customized

8–12 mg/week target

Maximum-efficacy phase · individual dose-response.

Step 1 · Initial WhatsApp screening

10-minute WhatsApp conversation with our medical team — eligibility, medical history, current medications, treatment goals. We confirm Bangkok-concierge fit before scheduling.

Step 2 · Scheduled in-person visit

Our medical team arrives at your Bangkok hotel, condo, or office with the lab-verified vials in a validated 2–8°C medical thermal container. The visit takes about 60 minutes: full protocol walkthrough, dose preparation demo, injection technique training, and your supervised first dose.

Step 3 · Monthly cold-chain delivery

Subsequent monthly supply arrives at your address by validated medical thermal courier — same-day delivery within Bangkok metropolitan area. No clinic-trip needed. Receipt is signed for and the cold-chain log is reviewed at every handover.

Step 4 · WhatsApp support throughout

Direct WhatsApp access to our medical team for the duration of your protocol — dose adjustments, side-effect management, response check-ins. Same-day reply during clinic hours.

Same-day

Bangkok metro

Order before noon · evening delivery. Sukhumvit, Silom, Sathorn, Asok, Phrom Phong, Thonglor, Ratchada, Lat Phrao.

Next-day

Major destinations

Phuket · Chiang Mai · Hua Hin · Koh Samui · Krabi · Pattaya (if you're not visiting our walk-in clinic).

1–2 days

Provincial Thailand

Chiang Rai · Udon Thani · Khon Kaen · Korat · Surat Thani · Nakhon Si Thammarat · all provincial capitals.

Validated medical thermal logistics

Every shipment travels in a validated medical thermal container with TempTale temperature loggers reviewed at every handover. Continuous 2–8°C from pharmacy release to your front door — no transcontinental shipping, no anonymous handoffs, no broken cold-chain.

What's in the box

Lab-verified Retatrutide vial(s) for the month · bacteriostatic water · sterile insulin syringes · alcohol swabs · sharps disposal container · written protocol card · printed reconstitution + injection guide · cold-chain certificate.

Remote video onboarding

Before your first delivery: a 30-minute video consultation with our medical team — protocol walkthrough, reconstitution demo, injection-technique demo. We don't ship before you're trained on safe self-administration.

WhatsApp medical support throughout

Direct WhatsApp access to our medical team for the full duration of your protocol. Dose questions, side-effect management, response check-ins. You're not alone after delivery — same-day reply during clinic hours.